Anti-platelet function of human endothelial cells: Augmentation by angiotensin-converting enzyme inhibitors?

Journal of Hypertension

Volumn 21, Issue 7, 2003, Pages 1259-1261

  Orzechowski, Hans Dieter ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; APYRASE; CANDESARTAN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSINOPRIL; G PROTEIN COUPLED RECEPTOR; INDAPAMIDE; LOSARTAN; NITRIC OXIDE SYNTHASE; PERINDOPRIL; PERINDOPRILAT; QUINAPRIL; RAMIPRIL; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; CONTROLLED STUDY; DRUG BLOOD LEVEL; EDITORIAL; ENDOTHELIUM CELL; ENZYME ACTIVITY; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOSIS; VASCULAR ENDOTHELIUM; DRUG EFFECT; NOTE; PHYSIOLOGY; THROMBOCYTE;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BLOOD PLATELETS; ENDOTHELIUM, VASCULAR; HUMANS;

EID: 0042769209     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-200307000-00010     Document Type: Editorial

References (16)

1. Lip GY, Blann AD, Beevers DG. Prothrombotic factors, endothelial function and left ventricular hypertrophy in isolated systolic hypertension compared with systolic-diastolic hypertension. J Hypertens 1999; 17:1203-1207.
2. Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost 2001; 86:222-232.
3. Savage B, Cattaneo M, Ruggeri ZM. Mechanisms of platelet aggregation. Curr Opin Hematol 2001; 8:270-276.
4. Jin J, Kunapuli SP. Coactivation of two different G protein-coupled receptors is essential for ADP-induced platelet aggregation. Proc Natl Acad Sci USA 1998; 95:8070-8074.
5. Marcus AJ, Safier LB, Hajjar KA, Ullman HL, Islam N, Broekman MJ, Eiroa AM. Inhibition of platelet function by an aspirin-insensitive endothelial cell ADPase. Thromboregulation by endothelial cells. J Clin Invest 1991; 88:1690-1696.
6. Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Alyonycheva TN, Safier LB, et al. The endothelial cell ecto-ADPase responsible for inhibition of platelet function is CD39. J Clin Invest 1997; 99:1351-1360.
7. Marcus AJ, Broekman MJ, Drosopoulos JH, Islam N, Pinsky DJ, Sesti C, Levi R. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleotidase-1: implications for ischemic vascular diseases. J Pharmacol Exp Ther 2003; 305:9-16.
8. Gayle RB III, Maliszewski CR, Gimpel SD, Schoenborn MA, Caspary RG, Richards C, et al. Inhibition of platelet function by recombinant soluble ecto-ADPase/CD39. J Clin Invest 1998; 101:1851-1859.
9. Kishi Y, Ohta S, Kasuya N, Sakita S, Ashikaga T, Isobe M. Perindopril augments ecto-ADPase activity and enhances endothelial anti-platelet function in human umbilical vein endothelial cells. J Hypertens 2003; 21:1347-1353.
10. Bavry AA, Li D, Zander DS, Phillips MI, Mehta JL. Inhibition of arterial thrombogenesis by quinapril but not Iosartan. J Cardiovasc Pharmacol Ther 2000; 5:121-127.
11. Riondino S, Pignatelli P, Pulcinelli FM, Lenti L, Di Veroli C, Marigliano V, Gazzaniga PP. Platelet hyperactivity in hypertensive older patients is controlled by lowering blood pressure. J Am Geriatr Soc 1999; 47:943-947.
12. Keidar S, Oiknine J, Leiba A, Shapira C, Leiba M, Aviram M. Fosinopril reduces ADP-induced platelet aggregation in hypertensive patients. J Cardiovasc Pharmacol 1996; 27:183-186.
13. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342:145-153.
14. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358:1033-1041.
15. Lees KR, Reid JL. Effects of intravenous S-9780, an angiotensin-converting enzyme inhibitor, in normotensive subjects. J Cardiovasc Pharmacol 1987; 10:129-135.
16. Lees KR, Reid JL. The haemodynamic and humeral effects of treatment for one month with the angiotensin converting enzyme inhibitor perindopril in salt replete hypertensive patients. Eur J Clin Pharmacol 1987; 31:519-524.